Development of Graphical User Interface for ARRBOD (Acute Radiation Risk and BRYNTRN Organ Dose Projection) by Kim, Myung-Hee et al.
 
 
NASA/TP-2010-xxxxx 
 
 
 
 
Development of Graphical User Interface for 
ARRBOD 
(Acute Radiation Risk and BRYNTRN Organ Dose 
Projection) 
 
 
 
 
Myung-Hee Y. Kim,1 Shaowen Hu,1 Hatem N. Nounu,1 and Francis A. Cucinotta2 
 
1Universities Space Research Association, Houston, TX  77058, USA 
2NASA Johnson Space Center, Houston, TX  77058, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2010
https://ntrs.nasa.gov/search.jsp?R=20100020906 2019-08-30T09:43:02+00:00Z
 
 
THE NASA STI PROGRAM OFFICE . . . IN PROFILE 
 
Since its founding, NASA has been 
dedicated to the advancement of aeronautics 
and space science. The NASA Scientific and 
Technical Information (STI) Program Office 
plays a key part in helping NASA maintain 
this important role. 
 
The NASA STI Program Office is operated 
by Langley Research Center, the lead center 
for NASA’s scientific and technical 
information. The NASA STI Program Office 
provides access to the NASA STI Database, 
the largest collection of aeronautical and 
space science STI in the world. The Program 
Office is also NASA’s institutional 
mechanism for disseminating the results of 
its research and development activities. 
These results are published by NASA in the 
NASA STI Report Series, which includes 
the following report types: 
• TECHNICAL PUBLICATION. Reports 
of completed research or a major 
significant phase of research that present 
the results of NASA programs and 
include extensive data or theoretical 
analysis. Includes compilations of 
significant scientific and technical data 
and information deemed to be of 
continuing reference value. NASA’s 
counterpart of peer-reviewed formal 
professional papers but has less stringent 
limitations on manuscript length and 
extent of graphic presentations. 
• TECHNICAL MEMORANDUM. 
Scientific and technical findings that are 
preliminary or of specialized interest, 
e.g., quick release reports, working 
papers, and bibliographies that contain 
minimal annotation. Does not contain 
extensive analysis. 
• CONTRACTOR REPORT. Scientific 
and technical findings by NASA-
sponsored contractors and grantees. 
• CONFERENCE PUBLICATION. 
Collected papers from scientific and 
technical conferences, symposia, 
seminars, or other meetings sponsored or 
cosponsored by NASA. 
• SPECIAL PUBLICATION. Scientific, 
technical, or historical information from 
NASA programs, projects, and mission, 
often concerned with subjects having 
substantial public interest. 
• TECHNICAL TRANSLATION 
English-language translations of foreign 
scientific and technical material 
pertinent to NASA’s mission. 
Specialized services that complement the 
STI Program Office’s diverse offerings 
include creating custom thesauri, building 
customized databases, organizing and 
publishing research results . . . even 
providing videos. 
 
For more information about the NASA STI 
Program Office, see the following: 
 
• Access the NASA STI Program Home 
Page at http://www.sti.nasa.gov 
 
• E-mail your question via the Internet to 
help@sti.nasa.gov 
 
• Fax your question to the NASA Access 
Help Desk at (301) 621-0134 
 
• Telephone the NASA Access Help Desk 
at (301) 621-0390 
 
• Write to: 
 NASA Access Help Desk 
 NASA Center for AeroSpace  
 Information 
 7115 Standard 
 Hanover, MD 21076-1320 
 
 
 
NASA/TP-2010-xxxxx 
 
 
 
 
Development of Graphical User Interface for 
ARRBOD 
(Acute Radiation Risk and BRYNTRN Organ Dose 
Projection) 
 
 
 
Myung-Hee Y. Kim,1 Shaowen Hu,1 Hatem N. Nounu,1  and Francis A. Cucinotta2 
 
1Universities Space Research Association, Houston, TX  77058, USA 
 
2NASA Johnson Space Center, Houston, TX  77058, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2010
  
Available from: 
 
NASA Center for AeroSpace Information National Technical Information Service 
7115 Standard Drive 5285 Port Royal Road 
Hanover, MD 21076-1320 Springfield, VA 22161 
301-621-0390 703-605-6000 
 
 
This report is also available in electronic form at http://ston.jsc.nasa.gov/collections/TRS/ 
 i 
 
Table of Contents 
Abstract ...................................................................................................................... 1 
1.  Introduction ........................................................................................................... 1 
2.  Measures of Radiation Exposure, NASA Limits, and Acute Severity 
Levels ............................................................................................................... 3 
3.  Stimulus and Response Sequences of SPE/Beam Exposure ................................ 4 
3.1  Input Control Parameters of BRYNTRN.INP ......................................................... 7 
3.2  Input Control Parameters of ARR.INP .................................................................... 8 
3.3  Overall I/O Sequences for ARR .............................................................................. 9 
4.  Overview of ARRBOD GUI .............................................................................. 10 
4.1  Option for SPE Exposure ....................................................................................... 12 
4.1.1  Preparing of BRYNTRN Inputs to Generate the Physical Dose .................... 12 
4.1.2  Viewing Options for Physical Quantities from SPE ....................................... 13 
4.1.3  Viewing Organ Dose for Male or Female....................................................... 15 
4.1.4  Preparing of ARR Inputs ................................................................................ 18 
4.2  Option for Radiation Exposure .............................................................................. 20 
5.  Illustration of Sample Results for the Protection of Astronauts in Space 
Missions ......................................................................................................... 22 
5.1  Organ Doses from Pre-defined Scenario of SPE  Exposure and Implication to 
Exposure Limits .................................................................................................... 22 
5.2  ARS from SPE or Radiation  Exposure ................................................................. 23 
5.2.1  ARS from SPE Exposure during EVA ........................................................... 23 
5.2.2  ARS from Acute/Protracted Exposure ............................................................ 25 
6.  Conclusions ......................................................................................................... 28 
References ................................................................................................................ 28 
 
 ii 
 
Tables 
Table 1.  Measures of Exposure. ......................................................................................... 3 
Table 2.  Exposure Limit by NASA for Deterministic and Prodromal Effect. ................... 4 
Table 3.  ARR Sickness at Severity Level. ......................................................................... 4 
Table 4.  Default Variables in Pre-defined Scenario .......................................................... 7 
Table 5.  Input Parameters of BRYNTRN.INP .................................................................. 7 
Table 6.  Input Parameters of ARR.INP ............................................................................. 8 
 
  
 iii 
 
Figures 
Figure 1.  Flow chart of physical dose calculations using the BRYNTRN and SUMDOSE 
modules for SPE exposure (label 1).  For the radiation exposure (label 2), go directly to 
the next step for the calculation of ARR. ............................................................................ 5 
Figure 2.  Flow chart of the ARR module. ......................................................................... 6 
Figure 3.  Overall input/output sequences of ARR calculations for 3 types of exposure: 1) 
Acute dose; 2) Protracted dose; and 3) SPE exposure during EVA. .................................. 9 
Figure 4.  Main task UI ..................................................................................................... 11 
Figure 5.  Input control UI of SPE .................................................................................... 12 
Figure 6.  Task UI for the selection of physical quantities viewing options, or for the next 
application flow. ............................................................................................................... 13 
Figure 7.  Graph and Output window for physical quantities ........................................... 14 
Figure 8.  Task UI for the selection of viewing options of organ doses, or for the next 
application flow. ............................................................................................................... 15 
Figure 9.  Graph and Output window for physical quantities and organ doses. ............... 16 
Figure 10.  Graph and Output window of organ dose comparisons to the NASA limits at 
various thicknesses, which is displayed by clicking “View NASA Organ Dose Limits”. 17 
Figure 11.  Input control UI of ARR for the selection of gender, EVA time, and 
spacecraft thickness. ......................................................................................................... 18 
Figure 12.  Graph and Output window for physical quantities, organ doses, and ARR.  
The tabulated information of ARR sickness of upper gastrointestinal distress (UG) and 
fatigability and weakness (FW) are added in this window and viewed by clicking “View 
ARR Sickness Severity Level Table”. .............................................................................. 19 
Figure 13.  Input control UI of ARR for the selection of exposure types for acute and 
protracted doses of radiation. ............................................................................................ 20 
Figure 14.  Graph and Output window of the ARR for the option of acute/protracted 
doses of radiation exposure.  The tabulated information of ARR sickness of upper 
gastrointestinal distress (UG) and fatigability and weakness (FW) is viewed by clicking 
“View ARR Sickness Severity Level Table” in this window. .......................................... 21 
Figure 15.  A sample result of the organ dose calculation for the pre-defined scenario for 
male (the same graph as in Fig. 10 as the one of the Graph and Output window). .......... 22 
Figure 16.  Input selection of ARR analysis in the case for a male astronaut who conducts 
3 hours of EVA and stays the remainder of 7 hours inside a spacecraft of 5 g/cm2 
thickness in the pre-defined scenario of SPE exposure. ................................................... 23 
Figure 17. Time profile of BFO dose accumulation of a male astronaut after 3-hr EVA. 24 
Figure 18.  The resultant sickness levels for UG and FW of a male astronaut after 3-hr 
EVA. ................................................................................................................................. 24 
Figure 19.  Acute radiation risk for the acute exposure to a given BFO dose: (a) upper GI 
distress (UG); and (b) fatigability and weakness (FW). ................................................... 26 
Figure 20.  Acute radiation risk from the uniform exposure to a given BFO dose for a 10- 
hour period: (a) upper GI distress (UG); and (b) fatigability and weakness (FW). .......... 27 
 iv 
 
ACRONYMS 
 
ALARA as low as reasonably achievable 
ARR acute radiation risk  
ARS acute radiation sickness 
ARRBOD acute radiation risk and BRYNTRN organ dose projection 
BFO blood forming organ  
BRYNTRN     baryon transport computer code 
CAF computerized anatomical female  
CAM computerized anatomical male  
EVA  extra vehicular activity  
FAX female adult voxel (volumetric and pixel) 
FW  fatigability and weakness 
GCR galactic cosmic radiation 
GUI graphical user interface 
GERM  GCR event-based risk model 
Gy  Gray  
Gy-Eq  Gray-Equivalent 
HZE high-charge and -energy nuclei  
HZETRN high-charge and -energy transport computer program 
ICRP  International Commission on Radiological Protection  
ISS  International Space Station 
JSC  Johnson Space Center 
LEO  low Earth orbit 
LET   linear energy transfer 
MAX male adult voxel (volumetric and pixel) 
MOD  mission operations directorate 
NASCA NASA study of cataracts in astronauts 
NCRP  National Council on Radiation Protection & Measurements 
NSRL  NASA Space Radiation Laboratory  
PEL  permissible exposure limit  
PRA  probabilistic risk assessment  
RBE  relative biological effectiveness 
REID  risk of exposure-induced death 
SPE  solar particle event 
SRPE  Space Radiation Program Element 
SUMDOSE summation of dose 
Sv  Sievert 
UG  upper gastrointestinal distress 
UI  user interface 
 
 
 
 
 1 
 
 
Abstract 
The space radiation environment, particularly solar particle events (SPEs), poses the risk 
of acute radiation sickness (ARS) to humans; and organ doses from SPE exposure may 
reach critical levels during extra vehicular activities (EVAs) or within lightly shielded 
spacecraft.  NASA has developed an organ dose projection model using the BRYNTRN 
with SUMDOSE computer codes, and a probabilistic model of Acute Radiation Risk 
(ARR).  The codes BRYNTRN and SUMDOSE, written in FORTRAN, are a Baryon 
transport code and an output data processing code, respectively.  The ARR code is 
written in C. The risk projection models of organ doses and ARR take the output from 
BRYNTRN as an input to their calculations.  BRYNTRN code operation requires 
extensive input preparation.  With a graphical user interface (GUI) to handle input and 
output for BRYNTRN, the response models can be connected easily and correctly to 
BRYNTRN in friendly way.  A GUI for the Acute Radiation Risk and BRYNTRN Organ 
Dose (ARRBOD) projection code provides seamless integration of input and output 
manipulations, which are required for operations of the ARRBOD modules: BRYNTRN, 
SUMDOSE, and the ARR probabilistic response model.  The ARRBOD GUI is intended 
for mission planners, radiation shield designers, space operations in the mission 
operations directorate (MOD), and space biophysics researchers. The ARRBOD GUI will 
serve as a proof-of-concept example for future integration of other human space 
applications risk projection models.  The current version of the ARRBOD GUI is a new 
self-contained product and will have follow-on versions, as options are added: 1) human 
geometries of MAX/FAX in addition to CAM/CAF; 2) shielding distributions for 
spacecraft, Mars surface and atmosphere; 3) various space environmental and biophysical 
models; and 4) other response models to be connected to the BRYNTRN.  The major 
components of the overall system, the subsystem interconnections, and external interfaces 
are described in this report; and the ARRBOD GUI product is explained step by step in 
order to serve as a tutorial. 
 
1.  Introduction 
 
 The potential for exposure to large solar particle events (SPEs) is a major concern 
during extra-vehicular activities (EVAs) on the lunar surface and during Earth-to-Lunar 
or Earth-to-Mars transit.  This includes the acute radiation syndrome from exposure to an 
intense SPE during an EVA or in a lightly shielded vehicle (< 5 g cm-2), as well as the 
increased risk of radiation induced cancers and degenerative diseases due to the 
cumulative organ doses from galactic cosmic rays (GCR) and multiple SPEs with intense 
particle flux and high energy levels (Cucinotta, 1999; Cucinotta et al. 2001; Cucinotta 
and Durante 2006).  Most SPEs would lead to small crew doses, although even a small 
SPE can disrupt mission operations and lead to excessive costs.  A real concern for the 
health risk to astronauts would be from SPEs with large proton fluences and effective 
doses exceeding 50 mSv.  The development of operational strategies and capabilities for 
the protection of astronauts from SPEs is an important consideration for the planning of 
future lunar surface scenarios, exploration of near Earth objects, and missions to Mars.   
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In NASA’s operational radiation protection program, career doses are monitored 
for individual astronauts, who engage in the space shuttle missions and/or the 
International Space Station (ISS), and best efforts are used to keep the risk as low as 
reasonably achievable (ALARA) (NCRP, 2000 and 2003).  Radiation exposures for 
astronauts corresponding to a 3% risk of exposure-induced death (REID) (NCRP, 2000, 
2003, Cucinotta et al., 2006), as well as short-term limits to avoid detrimental effects 
(NRC/NAS, 2008) are given as dose limits in radiation protection practices for space 
missions. 
 
NASA’s space radiation transport model of organ dose projection, which includes 
the baryon transport code BRYNTRN (Cucinotta et al., 1994; Wilson et al., 1989) and an 
output data processing code SUMDOSE, has been used to estimate the whole body 
effective dose for astronauts.  The radiation shielding by body tissue at specific organ 
sites was accounted for by using ray tracing in the human phantom models of the 
Computerized Anatomical Male (CAM), (Kase et al., 1970; Billings and Yucker, 1973) 
and the Computerized Anatomical Female (CAF), (Yucker and Hudston, 1990; Yucker, 
1992).  For human exposure, the dose-equivalent is defined by the product of the 
absorbed dose and the radiation quality factor Q, which compares the biological damage 
incurred from any ionizing radiation to the damage produced by γ-rays.  In general, Q is a 
function of linear energy transfer (LET).  For dose equivalent calculations (in Sv), the 
quality factors used are those defined by the International Commission on Radiological 
Protection in 1990 (ICRP 60).  The whole body effective dose, E, is defined as a 
weighted sum of organ dose equivalents over major sites for radiation cancer risks (ICRP, 
2007; NCRP, 2000, 2003) using the tissue weighting factors, wT (ICRP, 1991 & 2007). 
   
For space missions beyond LEO, the clinically significant deterministic health 
effects, including performance degradation in-flight, from the exposure to large SPEs 
must be prevented.  For the deterministic acute effects, the National Council for 
Radiological Protection (NCRP, 2000) has recommended that individual organ doses be 
made in terms of an alternate dose quantity denoted as the Gray-Equivalent (Gy-Eq), 
using the relative biological effectiveness (RBE), which is radiation-field dependent.  
Because biological effects are expected to increase significantly for dose-rates above 0.05 
Gy/h, the current 30-day permissible exposure limits (PELs) have been approved by 
NASA for skin, eye, and BFO as 1.5, 1.0, and 0.25 Gy-Eq (NCRP 2000, 2006), 
respectively.  For the estimation of deterministic acute effects from the intense SPEs 
during transition between and on the surface of the Moon or Mars missions, the new 
dosimetric quantity of organ dose (in Gy-Eq), was calculated using BRYNTRN with 
SUMDOSE by implementing the NCRP’s RBE together with the full definition of 
neutron RBE suggested by Wilson et al. (2002).  The resultant early radiation risks were 
assessed for the blood forming organ (BFO) dose by using an NASA-developed 
probabilistic model of acute radiation risk (ARR) (Anno et al. 1996; Hu et al. 2009).   
 
The purpose of the graphical user interface (GUI) development for ARRBOD is 
to provide seamless integration of input and output manipulations for the operations of 
projection modules (BRYNTRN, SUMDOSE, and the ARR probabilistic response 
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model) in assessing the acute risk and the organ doses of significant SPEs.  The 
ARRBOD GUI product will serve as a proof-of-concept for future integration of other 
risk projection models for human space applications. Future capabilities will include the 
ability of the user to supply a shield file of detailed geometry and SPE spectral 
measurement data of the radiation environment.  Also, the blood kinetics and the cataract 
risk projections based on NASCA (NASA study of cataracts in astronauts) and NSRL 
(NASA Space Radiation Laboratory) data will be added into the acute risk model.  The 
probabilistic risk assessment (PRA) approach using hazard functions will be added for 
SPE protection purposes.  Eventually, the galactic cosmic ray (GCR) event-based risk 
model (GERM) (Cucinotta et. al. 2010) will be developed in order to provide stochastic-
based estimates for GCR and SPE exposures.  
2.  Measures of Radiation Exposure, NASA Limits, and 
Acute Severity Levels  
 
Quantities used to describe radiation include the absorbed dose (D), dose 
equivalent (H), quality factor (Q), linear energy transfer (L), gray equivalent (Gy-Eq), 
effective dose (E), and relative biological effectiveness (RBE).  The absorbed dose is 
measured in Grays (Gy), energy absorbed per unit mass of material (1 Gy = 1 J per kg).  
Dose equivalent is measured in Sieverts (Sv), H =DxQ =  ∫Q(L) D(L) dL, where Q is the 
quality factor which represents the relative weighting of different types of radiation to 
produce stochastic biological effects compared to gamma-rays.  Gray equivalent is 
calculated as Gy-Eq = Σ (RBE)i Di , where RBEi is the relative biological effectiveness 
factor for deterministic effects produced as a result of exposure to type i particles, and Di 
is the dose due to type i particles.  The effective dose is measured in Sieverts (Sv), E = Σ 
wT HT , where wT is a weighting factor for tissue or organ type T, and HT is the dose 
equivalent averaged over tissue type T.  Measures of radiation exposure quantity are 
summarized in Table 1. 
 
Table 1.  Measures of Exposure. 
 Physical dose 
Dosimetric quantity for 
deterministic effects 
(typically acute response) 
Dosimetric quantity for 
stochastic (probabilistic) 
effects (typically cancer) 
Point Absorbed dose (D) 
Absorbed dose (D) or 
Gray-Equivalent (Gy-Eq)2 Dose equivalent (H)
1 
Organ/tissue Mean absorbed dose (DT) 
Gray-Equivalent (Gy-Eq)2 
Organ dose equivalent 
( )1 or Equivalent dose 
(HT)2 
Body   Effective dose (E)3 
1Absorbed dose is weighted by a quality factor that is a function of particle LET.  
2Absorbed dose is weighted by a radiation weighting factor that is a function of particle 
type.  3Absorbed dose is also weighted by type of tissue or organ. 
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The possibility of acute risk exists for a blood-forming organ (BFO) dose over 
500 mGy-Eq.  Dose limits for non-cancer radiation effects at BFO occur at doses below 
the threshold for prodromal effects.  The current NASA 30-day limits to BFO, lens, and 
skin for deterministic effects from space radiation and the minimum BFO dose for ARR 
are given in Table 2.  Symptoms of the early radiation effects at each severity levels are 
listed in Table 3 for the NASA-developed probabilistic model of acute radiation risk 
(Anno et al. 1996; Hu et al. 2009).   
 
Table 2.  Exposure Limit by NASA for Deterministic and Prodromal Effect. 
Exposure limit Organ dose, Gy-Eq 
30-d limit to Skin 1.5 
30-d limit to Lens 1.0 
30-d limit to BFO 0.25 
BFO dose limit without ARR 0.5 
 
Table 3.  ARR Sickness at Severity Level. 
Severity Upper Gastrointestinal Distress (UG) Fatigability and Weakness (FW) 
1 No effect No effect 
2 Upset stomach, clammy and sweaty, mouth waters 
Somewhat tired with mild 
weakness 
3 Nauseated, considerable sweating, swallows frequently to avoid vomiting 
Tired with moderate 
weakness 
4 Vomited once or twice, nauseated, and may vomit again Very tired and weak 
5 
Vomited several times, including the 
dry heaves, severe nauseated, and will 
soon vomit again 
Exhausted with almost no 
strength 
 
3.  Stimulus and Response Sequences of SPE/Beam 
Exposure 
 
The sequences of user actions and system responses that stimulate the behavior 
defined in the GUI feature are illustrated in Fig.1. Shown is a flow chart of the 
calculation of physical dose from SPE exposure (label 1 in Fig. 1) using BRYNTRN and 
SUMDOSE modules. There are three major control components: Input File Control, 
BRYNTRN Execution Control, and SUMDOSE Execution Control.  For radiation 
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exposure (label 2 in Fig. 1), those steps are entirely skipped to calculate directly ARR in 
the next step.  Fig. 2 shows the flow chart in the calculation of severity of sickness for 
upper gastrointestinal distress (UG) and fatigability and weakness (FW) under ARR 
Execution Control. 
 
 
 
Figure 1.  Flow chart of physical dose calculations using the BRYNTRN and SUMDOSE modules for 
SPE exposure (label 1).  For the radiation exposure (label 2), go directly to the next step for the 
calculation of ARR. 
BRYNTRN
Execution Control
BRYNTRN.EXE SUMDOSE.EXE
Dosimetry Output
Organ Dose Outputs
Input files:
Cafdists_NEW.dat
Camdists_HIP.dat
Input file:
Atomic.dat
Pop-up inputs:
ILOC
IDIST
ISPEC
IMAT
Generation of Input 
control file: 
BRYNTRN.INP
Input File Control
Input file
Physics Outputs
SUMDOSE
Print, View,
or
Save
Another BRYNTRN
Y
N
Y
Print, View,
or
Save
SUMDOSE
Execution Control
1.  Physical 
dose of SPE?
Or
2. ARR?  
1
ARR
2
N
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Figure 2.  Flow chart of the ARR module. 
 
  
Input:
Acute dose, Protracted dose, or Organ 
dose rate profile
Adjustment if given a profile:
Tpeak and Tbackground
FW.exe UGD.exe
Output:
Severity of sicknesses
Post-process:
View, print or save
ARR Execution Control
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3.1  Input Control Parameters of BRYNTRN.INP 
Input control parameters of BRYNTRN.INP are location, radiation field, fluence 
distribution of historical SPEs, and shield material.  Default values of input variables are 
listed in Table 4 for the pre-defined scenario.  Possible values for the selection of each 
variable are listed in Table 5. 
 
Table 4.  Default Variables in Pre-defined Scenario 
Location Radiation Field 
Fluence Distribution 
of Historical SPE 
Shield 
Material 
Interplanetary 
Space SPE Exponential Spectra Aug 1972 King Aluminum 
 
 
Table 5.  Input Parameters of BRYNTRN.INP 
Location Radiation Field Fluence Distribution of Historical SPEs 
Shield 
Material 
Interplanetary 
Space 
 
Or 
 
Lunar Surface 
SPE 
Exponential Spectra 
Feb 1956 
Aluminum, 
Polyethylene, 
CO2, 
Water, 
or 
Graphite 
Carbon 
Nov 1960 
Aug 1972 King  
Aug 1989 
Sep 1989 
Oct 1989 
Weibull Spectra 
Feb 1956 
Nov 1960  
Aug 1972  
Oct 1989  
Jul 2000  
Oct 2003  
Nov 2001  
Nov 2000  
Mar 1991  
Aug 1989  
Sep 1989  
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3.2  Input Control Parameters of ARR.INP 
There are 3 exposure types available for the calculation of ARR: 1) Acute beam 
exposure, 2) Protracted dose exposures of radiation beam, and 3) SPE exposure during 
EVA.  Input control parameters for ARR.INP are:  total BFO dose in acute dose 
exposure; total BFO dose and exposure time in protracted dose exposure; and EVA 
duration, gender of astronaut, and choice of spacecraft thickness with organ doses 
calculated from the selected SPE exposure.  Table 6 summarizes the input control 
parameters of ARR for the 3 exposure types and the ranges of variables. 
 
Table 6.  Input Parameters of ARR.INP 
ARR Application Directly 
due to the Exposure from Acute/Protracted Dose 
Defined by User 
ARR Application with 
BRYNTRN+SUMDOSE 
due to the Exposure from a 
Historically Large SPE 
1)  Acute 
Exposure 
2)  Protracted 
Exposure 3)  SPE Exposure 
Acute dose in Gy-eq:  
[0.47* - 28.17]  
Protracted dose in Gy-eq: 
[0.47* - 28.17]  
Male or Female: 
 Gender-specific total BFO 
dose inside spacesuit from the 
selected SPE exposure to be used.  
Exposure time in hr: 
[0.1 – 168.0] 
EVA time in hr: 
[0.0 – 10.0] 
Shielding thickness: 
[0.3, 1, 5, 10, 15, 20, or 30 g/cm2] 
 Gender-specific BFO dose 
inside spacecraft at specified 
shielding thickness from the 
selected SPE exposure  to be used. 
*No acute radiation risk if total BFO dose < 0.47 Gy-Eq. 
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3.3  Overall I/O Sequences for ARR 
Overall input/output sequences of ARR calculations are illustrated in Fig. 3 for 3 
exposure types. 
  
 
Figure 3.  Overall input/output sequences of ARR calculations for 3 types of exposure: 1) Acute dose; 
2) Protracted dose; and 3) SPE exposure during EVA. 
  
ARR directly?
y
Total BFO dose in Gy-Eq?
Exposure time, hr?
Go to Main
ARR
More ARR
y
End
2) Protracted dose
ARR directly
or 
Organ dose
y
n
n
Exposure type
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Total BFO dose in
Gy-Eq?
directly
n BRYNTRN+SUMDOSE
3) SPE exposure
EVA duration in hr?
BFOMale(x) from SUMDOSE_CAM.dat 
BFOFemale(x) from SUMDOSE_CAF.dat
BFOMale(EVA) 
Pull down menu
for Spacecraft:
BFOcraft= BFOMale(x) 
SPE Organ dose
Gender
BFOFemale(EVA) 
EVA duration in hr?
Pull down menu
for Spacecraft:
BFOcraft= BFOFemale(x) 
Male Female
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4.  Overview of ARRBOD GUI  
 
 As an application of ARRBOD GUI starts, it launches the banner below for a 
brief time period.  It says that ARRBOD v 1.0 is developed at the NASA Johnson Space 
Center, Space Radiation Program Element (SRPE), in 2009. 
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The next screen is the main task user interface (UI) of ARRBOD application flow 
(Fig. 4).  From this main task UI, the user has two options for the selection of either:  (1) 
evaluation of physics and organ doses from historically large SPEs; or (2) do the acute 
risk analysis directly. 
 
 
 
Figure 4.  Main task UI  
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4.1  Option for SPE Exposure 
4.1.1  Preparing of BRYNTRN Inputs to Generate the Physical Dose 
 
For the selection of option 1 in the main task UI for the evaluation of physics and 
organ doses from historically large SPEs, the following input control UI of SPE (Fig. 5) 
appears.  In this input control UI of SPE, the user can make either the selection of the 
default scenario of the August 1972 SPE (Table 4) or the manual selection for the input 
parameters listed in Table 5 to generate the BRYNTRN.INP file.  By clicking “Generate 
Physics Dose”, the BRYNTRN code is executed with the input variables selected by the 
user. 
 
 
 
Figure 5.  Input control UI of SPE 
 
  
 13 
 
4.1.2  Viewing Options for Physical Quantities from SPE  
 
Physical quantities generated from the execution of BRYNTRN code can be 
viewed for 1) physical dosimetry (D, G, H), or 2) LET spectra, by selecting the viewing 
option from the task UI in Fig. 6. 
 
 
 
Figure 6.  Task UI for the selection of physical quantities viewing options, or for the next application 
flow. 
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In the selection of viewing option “Physical Dosimetry” (Fig. 7), outputs of 
absorbed dose of physical dose (D), Gray-equivalent adjusted for acute risk (G), and 
dose-equivalent adjusted for long-term risk (H) are viewed as a function of tissue 
thickness at a given shielding thickness (x=0.3, 1, 5, 10, 15, 20 or 30 g/cm2).  In the 
“View Data” window, those output data are tabulated also in text format.    
Linear energy transfer (LET) spectra at various shielding thicknesses can be 
viewed by clicking the corresponding tab “LET Spectra” in the same output window (in 
Fig. 7) or by clicking “Show Tasks” to go back to the previous task UI (Fig. 6), and then 
selecting the viewing option for LET in that task UI.  In the current viewing option of 
“LET Spectra”, data of LET spectra are viewed by clicking “View Data” and saving them 
as a text file.  The graph can be printed directly and also can be saved separately in a 
working directory.  The ARRBOD application for SPE is continued by clicking “Show 
Tasks” to go back to the task UI (Fig. 6) and then clicking “Generate Organ Dose” in the 
task UI for the next application flow of step three. 
 
 
 
  Figure 7.  Graph and Output window for physical quantities 
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4.1.3  Viewing Organ Dose for Male or Female 
 
Organ dose quantities for male or female can be viewed by selecting organ dose 
output for male or female in the SUMDOSE task UI in Fig. 8.  
 
 
 
 Figure 8.  Task UI for the selection of viewing options of organ doses, or for the next application 
flow. 
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Organ doses at various organ/tissue sites, whole body effective dose, and point 
dose without body shielding are viewed in terms of absorbed dose (D), Gray-equivalent 
dose (G), and dose-equivalent (H) at a given shielding thickness.  The result data are 
viewed and saved as text files for male or female.  The graph can be printed directly and 
also saved in a separate working directory.   
 
 
 
Figure 9.  Graph and Output window for physical quantities and organ doses.   
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In the graph and output window for physical quantities and organ doses, an added 
feature is “View NASA Organ Dose Limits”.  By clicking it, the organ doses of male or 
female for skin, eye, and blood forming organ (BFO) at each shielding thickness are 
easily compared to the color-coded parallel lines, which are NASA exposure limits for 
deterministic and prodromal effects (Table 2), as shown in Fig. 10. 
 
 
 
Figure 10.  Graph and Output window of organ dose comparisons to the NASA limits at various 
thicknesses, which is displayed by clicking “View NASA Organ Dose Limits”. 
 
The ARRBOD application for SPE is performed by clicking “Show Tasks” and 
then clicking “Start Acute Radiation Risk” in the task UI (Fig. 8), the next application in 
the flow of step four. 
  
 18 
 
4.1.4  Preparing of ARR Inputs  
 
Using the SPE exposure calculated from the previous three steps, gender-specific 
total BFO dose inside the spacesuit is assigned automatically to “BFO EVA dose” for the 
calculation of ARR, once the astronaut’s gender is specified by the user.  Additional input 
variables required are: 1) EVA duration, which ranges from 0 to 10 hours; and 2) the 
selection of a spacecraft shielding thickness to be used as a shelter against the SPE 
exposure during EVA far from the surface habitat.  By the selection of a spacecraft 
thickness, gender-specific BFO dose inside a spacecraft of specified thickness is assigned 
for the calculation of ARR.  BFO dose rates during the EVA and inside the spacecraft are 
assumed to be those at the peak fluence of the SPE for the 10-hour duration. 
   
 
 
Figure 11.  Input control UI of ARR for the selection of gender, EVA time, and spacecraft thickness.     
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By clicking “Generate Acute Radiation Risk” in the input control UI of ARR (Fig. 
11), two outputs: “Exposure Summary” and “Acute Radiation Risk” are generated and 
added into the Graphs and Output window.  The ARR results are represented as severity 
levels ranging from 1 to 5 for upper gastrointestinal distress (UG) and fatigability and 
weakness (FW), which are tabulated and added into the Graphs and Output window as 
“View ARR Sickness Severity Level Table”. 
 
 
 
Figure 12.  Graph and Output window for physical quantities, organ doses, and ARR.  The tabulated 
information of ARR sickness of upper gastrointestinal distress (UG) and fatigability and weakness 
(FW) are added in this window and viewed by clicking “View ARR Sickness Severity Level Table”. 
 
Once all the results have been viewed in each step of the application flow after the 
execution of each module of BRYNTRN, SUMDOSE, and ARR, they are accumulated in 
the Graphs and Output window to be viewed/printed/saved at the end of the ARRBOD 
application flow.  These result tabs are “LET Spectra” and “Physical Dosimetry” from 
the BRYNTRN module; “NASA Organ Dose Limits” and “Organ Dose” from the 
SUMDOSE module; “Exposure Summary” and “Acute Radiation Risk” from the ARR 
module; and “View ARR Sickness Severity Level Table” for the symptoms of quantified 
ARR severity level.  
 
By clicking “Show Tasks”, the ARRBOD application for SPE can be continued 
by returning to the previous flow, or the entire application can be started over. 
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4.2  Option for Radiation Exposure 
 
The second option of the ARRBOD application is the direct analysis of ARR.  
This option determines the calculation of ARR from the user-defined radiation dose.  It is 
selected by clicking “Run Acute Radiation analysis directly” in the main task UI of 
ARRBOD application in Fig. 4.   
In the input control UI of ARR, there are two options of radiation exposure type 
(Fig. 13): acute and protracted doses of radiation.  Total BFO doses from 0.47 to 28.17 
Gy-Eq are considered for the analysis of ARR for both acute and protracted exposure 
types.  For the protracted dose exposure, possible exposure times can be inputted from 
0.1 to 168 hours.  However, dose rates ( ) of protracted exposure should be less than 5 
Gy-Eq/hr from any combination of total dose (Dtotal) and exposure time (texposure).   
 .  
In the case that the dose rate exceeds 5 Gy-Eq/hr from the combination of total dose and 
exposure time, the ARRBOD application results in an error with the dummy outputs.  
Inclusion of the correct error message is planned.  By definition, acute exposure is quite 
representative for these high dose rates, and the user is advised to select “Use Acute 
Dose” from the input control UI (Fig. 13) to get the appropriate ARR analysis for the 
given total BFO dose. 
  
 
 
Figure 13.  Input control UI of ARR for the selection of exposure types for acute and protracted 
doses of radiation.  
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After execution of the ARR module, two outputs, “Exposure Summary” and 
“Acute Radiation Risk”, are displayed in the Graphs and Output window.  ARR results 
are represented as severity levels ranging from 1 to 5 for upper gastrointestinal distress 
(UG) and fatigability and weakness (FW).  The symptoms at each severity levels are 
tabulated in the “View ARR Sickness Severity Level Table” and added into the Graphs 
and Output window.  By clicking “View ARR Sickness Severity Level Table”, the table 
is viewed as in Fig. 14. 
 
 
 
Figure 14.  Graph and Output window of the ARR for the option of acute/protracted doses of 
radiation exposure.  The tabulated information of ARR sickness of upper gastrointestinal distress 
(UG) and fatigability and weakness (FW) is viewed by clicking “View ARR Sickness Severity Level 
Table” in this window. 
 
The ARR analysis of radiation exposure is continued by clicking “Execute ARR 
Directly” for different beams, or the entire application of ARRBOD can be started over 
by clicking “Show Tasks” to go back to the input control UI of ARR (Fig. 13) and then 
clicking “Start Over”. 
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5.  Illustration of Sample Results for the Protection of Astronauts in 
Space Missions 
5.1  Organ Doses from Pre-defined Scenario of SPE  Exposure and 
Implication to Exposure Limits 
 
In the pre-defined scenario of SPE exposure in ARRBOD application, it is 
assumed that a crew member is located inside an aluminum spacecraft in interplanetary 
space and exposed to an August 1972-type SPE, characterized by the exponential 
distribution of 1972 King spectrum.   
The current NASA 30-day permissible exposure limits (PELs) are 1.5, 1.0, and 
0.25 Gy-Eq (NCRP 2000, 2006) for skin, lens of the eye, and BFO, respectively.  The 
threshold for prodromal effects is 0.5 Gy-Eq, because the possibility of acute risk exists 
for BFO dose over this level (Hu et al., 2009).  Future research is needed to understand if 
microgravity effects modify this threshold value.   
The results for males in this scenario are shown in Fig. 15.  The resultant organ 
dose assessments are compared with the current NASA 30-day dose limits and the 
threshold for acute radiation sickness (ARS).  From this figure, sufficient shielding can 
be determined to avoid ARS, and to stay within the NASA short-term limits.  For 
example, a male crew member, located inside a spacecraft with 5 g/cm2 aluminum 
shielding during interplanetary transit, may not experience any ARS, because the BFO 
dose is determined to be lower than the 0.5 Gy-Eq threshold.  However, organ dose 
assessments of skin, lens of the eye, and BFO exceed the current NASA 30-day dose 
limits of these organs.  Therefore, more than 5 g/cm2 of aluminum shielding are required 
during interplanetary transit to protect astronauts against a large August 1972-type SPE.  
 
    
 
 
Figure 15.  A sample result of the organ dose calculation for the pre-defined scenario for male (the 
same graph as in Fig. 10 as the one of the Graph and Output window). 
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5.2  ARS from SPE or Radiation  Exposure 
5.2.1  ARS from SPE Exposure during EVA 
 In the case of a male astronaut conducting 3 hours of EVA and then sheltering 
inside a 5 g/cm2 aluminum spacecraft for 7 hours in this pre-defined scenario of SPE 
exposure, the input selection of the ARS analysis is shown in Fig. 16.  It is assumed that 
the EVA occurs at the peak hours of the SPE, and that the total peak duration is 10 hours.  
 
 
 
 
Figure 16.  Input selection of ARR analysis in the case for a male astronaut who conducts 3 hours of 
EVA and stays the remainder of 7 hours inside a spacecraft of 5 g/cm2 thickness in the pre-defined 
scenario of SPE exposure. 
 
 
A male astronaut’s time profile of BFO dose accumulation is shown in Fig. 17, 
which also provides an exposure summary.  It shows that a total BFO dose of 74.03 cGy-
Eq is accumulated at the end of the SPE, which is 10 hours after the initial exposure.   
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Figure 17. Time profile of BFO dose accumulation of a male astronaut after 3-hr EVA. 
 
 
The resultant sickness levels for UG and FW are shown in Fig. 18 as acute 
radiation risk level.  It shows that a male astronaut may not have any symptoms during 
the 3-hour EVA, however the initial ARR symptoms appear after he finds shelter.  These 
symptoms include upset stomach, clammy and sweaty skin, and mouth watering (level 2 
of UG distress).  Long-lasting symptoms endure: tiredness and mild weakness (sub-level 
2 of FW).   
 
 
Figure 18.  The resultant sickness levels for UG and FW of a male astronaut after 3-hr EVA. 
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5.2.2  ARS from Acute/Protracted Exposure 
 
The input selection for ARS analysis from acute exposure is shown in Fig. 13. For 
acute dose exposure, the user-supplied total BFO dose ranges from 0.47 to 28.17 Gy-Eq.  
The output results of the acute doses are summarized in Fig. 19a for UG and Fig. 19b for 
FW, respectively.  In these figures, the BFO dose ranges are 0.5 - 1.0 Gy-Eq with 
increments of 0.1 Gy-Eq and 1.0 – 3.0 Gy-Eq with increment of 0.5 Gy-Eq.  As the acute 
BFO dose increases to 3 Gy-Eq, the possible symptoms for UG level 5 include vomiting 
several times, showing dry heaves, severe nausea, and vomiting again shortly after 7 
hours following the exposure.  Long-lasting symptoms of FW from the acute exposure 
dose of 3 Gy-Eq are at the levels between 2 and 4, which include being somewhat tired 
with mild weakness, to being tired with moderate weakness, and to being very tired and 
weak. 
 
In the protracted exposure for 10 hours of time, the results for the same doses as 
those of acute exposure are summarized in Fig. 20a for UG and Fig. 20b for FW, 
respectively.  In this uniform exposure of 10 hour duration, dose rates vary between 0.05 
– 0.1 Gy-Eq/hr with increments of 0.01 Gy-Eq/hr, and 0.1 – 0.3 Gy-Eq/hr with 
increments of 0.05 Gy-Eq/hr.  Maximum severities of UG and FW for 10-hour uniform 
exposures are similar to those of acute exposures.  The delayed response is shown to be 
significantly shorter for the 10 hour uniform exposure, when the time profiles are 
compared. 
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Figure 19.  Acute radiation risk for the acute exposure to a given BFO dose: (a) upper GI distress 
(UG); and (b) fatigability and weakness (FW).  
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Figure 20.  Acute radiation risk from the uniform exposure to a given BFO dose for a 10- hour 
period: (a) upper GI distress (UG); and (b) fatigability and weakness (FW).  
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6.  Conclusions 
 
The assessment of astronauts’ radiation risk from SPE is an important goal in 
support of mission design and operational planning to manage radiation risks in future 
space missions. The first version of the ARRBOD GUI is developed for the purpose of 
NASA trade studies of mission scenarios, including studies of shielding materials, masses 
and topologies from exposure to historically recorded large SPEs.  In the current 
ARRBOD version, proper shielding solutions can be identified from the gender-specific 
organ dose assessments to avoid ARR symptoms, and to stay within the current NASA 
short-term dose limits.  Furthermore, the quantified evaluation of ARR severities based 
on any given shielding configuration and a specified EVA or other mission scenario can 
be made to guide alternative solutions for attaining determined objectives set by mission 
planners. 
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